Disease-A-Month
Volume 55, Issue 4 , Pages 236-256 , April 2009

Skin Fillers

References 

  1. In:  Shiffman MA editors. Autologous Fat Transplantation. New York, NY: Marcel Dekker; 2001;
  2. Murray CA, Zloty D, Warshawski L. The evolution of soft tissue fillers in clinical practice. Dermatol Clin. 2005;23(2):343–363
  3. Duffy DM. Liquid silicone for soft tissue augmentation. Dermatol Surg. 2005;31(11 Pt 2):1530–1541
  4. Bauman L. CosmoDerm/CosmoPlast (human bioengineered collagen) for the aging face. Facial Plast Surg. 2004;20(2):125–128
  5. Johl SS, Burgett RA. Dermal filler agents: a practical review. Curr Opin Ophthalmol. 2006;17(5):471–479
  6. Naoum C, Dasiou-Plakida D. Dermal filler materials and botulin toxin. Int J Dermatol. 2001;40(10):609–621
  7. Owens JM. Soft tissue implants and fillers. Otolaryngol Clin North Am. 2005;38(2):361–369
  8. Millikan L, Banks K, Purkait B, et al. A 5-year safety and efficacy evaluation with fibrel in the correction of cutaneous scars following one or two treatments. J Dermatol Surg Oncol. 1991;17(3):223–229
  9. Monheit GD, Coleman KM. Hyaluronic acid fillers. Dermatol Ther. 2006;19(3):141–150
  10. Narins RS, Bowman PH. Injectable skin fillers. Clin Plast Surg. 2005;32(2):151–162
  11. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg. 2003;29(6):588–595
  12. Rao J, Chi GC, Goldman MP. Clinical comparison between two hyaluronic acid-derived fillers in the treatment of nasolabial folds: hylaform versus restylane. Dermatol Surg. 2005;31(11 Pt 2):1587–1590
  13. Matarasso SL, Carruthers JD, Jewell ML. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg. 2006;117(3):3S–34Sdiscussion 35S-43S (suppl)
  14. Baumann L. Replacing dermal constituents lost through aging with dermal fillers. Semin Cutan Med Surg. 2004;23(3):160–166
  15. Sclafani AP, Romo T, Jacono AA, et al. Evaluation of acellular dermal graft (AlloDerm) sheet for soft tissue augmentation: a 1-year follow-up of clinical observations and histological findings. Arch Facial Plast Surg. 2001;3(2):101–103
  16. Vleggaar D. Facial volumetric correction with injectable poly-L-lactic acid. Dermatol Surg. 2005;31(11 Pt 2):1511–1517discussion 1517-8
  17. Valantin MA, Aubron-Olivier C, Ghosn J, et al. Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS. 2003;l17(17):2471–2477
  18. Moyle GJ, Lysakova L, Brown S, et al. A randomized open-label study of immediate versus delayed polylactic acid injections for the cosmetic management of facial lipoatrophy in persons with HIV infection. HIV Med. 2004;5(2):82–87
  19. Flaharty P. Radiance. Facial Plast Surg. 2004;20(2):165–169
  20. Hamilton TK. Assessing nonsurgical options for facial restoration. Dermatol Ther. 2007;20(suppl 1):S5–S9
  21. Thaler MP, Ubogy ZI. Artecoll: the Arizona experience and lessons learned. Dermatol Surg. 2005;31(11 Pt 2):1566–1574
  22. Nicolau PJ. Long-lasting and permanent fillers: biomaterial influence over host tissue response. Plast Reconstr Surg. 2007;119(7):2271–2286
  23. van Wachem PB, Schakenraad JM, Feijen J, et al. Adhesion and spreading of cultured endothelial cells on modified and unmodified poly (ethylene terephthalate): a morphological study. Biomaterials. 1989;10(8):532–539
  24. Brodbeck WG, Shive MS, Colton E, et al. Influence of biomaterial surface chemistry on the apoptosis of adherent cells. J Biomed Mater Res. 2001;55(4):661–668
  25. Tomazic-Jezic VJ, Merritt K, Umbreit TH. Significance of the type and the size of biomaterial particles on phagocytosis and tissue distribution. J Biomed Mater Res. 2001;55(4):523–529
  26. Anderson JM. Multinucleated giant cells. Curr Opin Hematol. 2000;7(1):40–47
  27. Morhenn VB, Lemperle G, Gallo RL. Phagocytosis of different particulate dermal filler substances by human macrophages and skin cells. Dermatol Surg. 2002;28(6):484–490
  28. Lemperle G, Morhenn VB, Pestonjamasp V, et al. Migration studies and histology of injectable microspheres of different sizes in mice. Plast Reconstr Surg. 2004;113(5):1380–1390
  29. Pannek J, Brands FH, Senge T. Particle migration after transurethral injection of carbon coated beads for stress urinary incontinence. J Urol. 2001;166(4):1350–1353
  30. Sanger JR, Kolachalam R, Komorowski RA, et al. Short-term effect of silicone gel on peripheral nerves: a histologic study. Plast Reconstr Surg. 1992;89(5):931–940discussion 941-2
  31. Matlaga BF, Yasenchak LP, Salthouse TN. Tissue response to implanted polymers: the significance of sample shape. J Biomed Mater Res. 1976;10(3):391–397
  32. Gelb H, Schumacher HR, Cuckler J, et al. In vivo inflammatory response to polymethylmethacrylate particulate debris: effect of size, morphology, and surface area. J Orthop Res. 1994;12(1):83–92
  33. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg. 2003;29(6):573–587
  34. Smetana K. Cell biology of hydrogels. Biomaterials. 1993;14(14):1046–1050
  35. Rizzi SC, Heath DJ, Coombes AG, et al. Biodegradable polymer/hydroxyapatite composites: surface analysis and initial attachment of human osteoblasts. J Biomed Mater Res. 2001;55(4):475–486
  36. Eppley BL, Summerlin DJ, Prevel CD, et al. Effects of a positively charged biomaterial for dermal and subcutaneous augmentation. Aesthetic Plast Surg. 1994;18(4):413–416
  37. Stegman S, Chu S, Armstrong R. Adverse reactions to bovine collagen implant: clinical and histologic features. J Dermatol Surg. 2003;29:588–595
  38. DeLustro F, Smith ST, Sundsmo J, et al. Reaction to injectable collagen: results in animal models and clinical use. Plast Reconstr Surg. 1987;79(4):581–594
  39. Cooperman LS, Mackinnon V, Bechler G, et al. Injectable collagen: a six-year clinical investigation. Aesthetic Plast Surg. 1985;9(2):145–151
  40. Hanke CW, Higley HR, Jolivette DM, et al. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol. 1991;25(2 Pt 1):319–326
  41. Narins RS, Jewell M, Rubin M, et al. Clinical conference: management of rare events following dermal fillers–focal necrosis and angry red bumps. Dermatol Surg. 2006;32(3):426–434
  42. Friedman PM, Mafong EA, Kauvar AN, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg. 2002;28(6):491–494
  43. Andre P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA – Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol. 2004;18(4):422–425
  44. Lupton JR, Alster TS. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol Surg. 2000;26(2):135–137
  45. Brody HJ. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg. 2005;31(8 Pt 1):893–897
  46. Micheels P. Human anti-hyaluronic acid antibodies: is it possible?. Dermatol Surg. 2001;27(2):185–191
  47. Shafir R, Amir A, Gur E. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast Reconstr Surg. 2000;106(5):1215–1216
  48. Hirsch RJ, Carruthers JD, Carruthers A. Infraorbital hollow treatment by dermal fillers. Dermatol Surg. 2007;33(9):1116–1119
  49. Hirsch RJ, Narurkar V, Carruthers J. Management of injected hyaluronic acid induced Tyndall effects. Lasers Surg Med. 2006;38(3):202–204
  50. Hirsch RJ, Cohen JL, Carruthers JD. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg. 2007;33(3):357–360
  51. Hirsch RJ, Lupo M, Cohen JL, et al. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase. J Drugs Dermatol. 2007;6(3):325–328
  52. Spenlehauer G, Vert M, Benoit JP, et al. In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials. 1989;10(8):557–563
  53. Woerle B, Hanke CW, Sattler G. Poly-L lactic acid: a temporary filler for soft tissue augmentation. J Drugs Dermatol. 2004;3(4):385–389
  54. Sklar JA, White SM. Radiance FN: A new soft tissue filler. Dermatol Surg. 2004;30(5):764–768
  55. Beer KR. Radiesse nodule of the lips from a distant injection site: report of a case and consideration of etiology and management. J Drugs Dermatol. 2007;6(8):846–847
  56. Alcalay J, Alcalay R, Gat A, et al. Late-onset granulomatous reaction to Artecoll. Dermatol Surg. 2003;29(8):859–862
  57. Saylan Z. Facial fillers and their complications. Aesthetic Surg J. 2003;23(3):221–224
  58. Carruthers JD, Carruthers A. Facial sculpting and tissue augmentation. Dermatol Surg. 2005;31(11 Pt 2):1604–1612
  59. Bergeret-Galley C, Latouche X, Illouz YG. The value of a new filler material in corrective and cosmetic surgery: Dermalive and Dermadeep. Aesthetic Plast Surg. 2001;25(4):249–255
  60. Rudolph CM, Soyer HP, Schuller-Petrovic S, et al. Foreign body granulomas due to injectable aesthetic microimplants. Am J Surg Pathol. 1999;23(1):113–117
  61. Achauer BM. A serious complication following medical-grade silicone injection of the face. Plast Reconstr Surg. 1983;71(2):251–254
  62. Pearl RM, Laub DR, Kaplan EN. Complications following silicone injections for augmentation of the contours of the face. Plast Reconstr Surg. 1978;61(6):888–891
  63. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg. 2006;118(3):92S–107Ssuppl
  64. Reisberger EM, Landthaler M, Wiest L, et al. Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol. 2003;139(1):17–20
  65. Zager W, Huang J, McCue P, et al. Laser resurfacing of silicone-injected skin: the “silicone flash” revisited. Arch Otolaryngol Head Neck Surg. 2001;127(4):418–421
  66. Vargas-Machuca I, González-Guerra E, Angulo J, et al. Facial granulomas secondary to Dermalive microimplants: report of a case with histopathologic differential diagnosis among the granulomas secondary to different injectable permanent filler materials. Am J Dermatopathol. 2006;28(2):173–177

PII: S0011-5029(09)00004-2

doi: 10.1016/j.disamonth.2009.01.002

Disease-A-Month
Volume 55, Issue 4 , Pages 236-256 , April 2009

Article Tools